← Open Payments lookup

SARAH HART: Open Payments

NPI 1013339522 · OKLAHOMA CITY, OK. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$1,294 in 59 payments from 9 companies in 2025. Trend: 2023 $592 · 2024 $734 · 2025 $1,294

Food & beverage: $1,294
CompanyPaymentsAmount
Madrigal Pharmaceuticals16$538
Gilead Sciences, Inc.15$277
Ipsen Biopharmaceuticals, Inc10$171
Salix Pharmaceuticals, a division of Bausch Health US, LLC11$151
Intercept Pharmaceuticals, Inc.3$62
Takeda Pharmaceuticals U.S.A., Inc.1$31
Eton Pharmaceuticals, Inc.1$24
Boston Scientific Corporation1$23
ABBVIE INC.1$16

Products named: REZDIFFRA, IQIRVO, XIFAXAN, OCALIVA, LIVTENCITY, ALKINDI, WATCHMAN, MAVYRET.

Industry payments across OK — which companies pay providers there.